MedTech Solutions (WAR:MDT) Cyclically Adjusted Revenue per Share: zł0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDT MedTech Solutions SA WAR:MDT
39 GF Score
Price zł0.30
GF Value zł0.04
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is MedTech Solutions Cyclically Adjusted Revenue per Share?

MedTech Solutions WAR:MDT +2.70% 39 Cyclically Adjusted Revenue per Share is zł0.00 as of Mar. 2026. GuruFocus rates WAR:MDT with a GF Score™ of 39/100 and a GF Value™ of zł0.04 (Significantly Overvalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

MedTech Solutions's adjusted revenue per share for the three months ended in Mar. 2026 was zł0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł0.00 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-23), MedTech Solutions's current stock price is zł0.304. MedTech Solutions's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was zł0.00. MedTech Solutions's Cyclically Adjusted PS Ratio of today is .

During the past 12 years, the highest Cyclically Adjusted PS Ratio of MedTech Solutions was 3.65. The lowest was 0.59. And the median was 0.81.


MedTech Solutions  (WAR:MDT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of MedTech Solutions was 3.65. The lowest was 0.59. And the median was 0.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


MedTech Solutions Cyclically Adjusted Revenue per Share Related Terms


MedTech Solutions Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for MedTech Solutions's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedTech Solutions Cyclically Adjusted Revenue per Share Chart

MedTech Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.40

MedTech Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.41 0.00 0.40 0.00

WAR:MDT vs AMZN, BABA, PDD: Cyclically Adjusted Revenue per Share Comparison

For the Internet Retail subindustry, MedTech Solutions's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedTech Solutions Cyclically Adjusted PS Ratio vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, MedTech Solutions's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MedTech Solutions's Cyclically Adjusted PS Ratio falls into.


WAR:MDT
39GF Score
MedTech Solutions SA WAR:MDT
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedTech Solutions Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MedTech Solutions's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/163.0700*163.0700
=0.000

Current CPI (Mar. 2026) = 163.0700.

MedTech Solutions Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.015 99.552 0.025
201609 1.512 99.064 2.489
201612 0.090 100.366 0.146
201703 0.174 101.018 0.281
201706 0.069 101.180 0.111
201709 0.050 101.343 0.080
201712 0.017 102.564 0.027
201803 0.020 102.564 0.032
201806 0.023 103.378 0.036
201809 0.017 103.378 0.027
201812 0.014 103.785 0.022
201903 0.015 104.274 0.023
201906 0.010 105.983 0.015
201909 0.008 105.983 0.012
201912 0.008 107.123 0.012
202003 0.007 109.076 0.010
202006 0.003 109.402 0.004
202009 0.007 109.320 0.010
202012 0.007 109.565 0.010
202103 0.006 112.658 0.009
202106 0.002 113.960 0.003
202109 0.012 115.588 0.017
202112 0.038 119.088 0.052
202203 0.000 125.031 0.000
202206 0.000 131.705 0.000
202209 0.000 135.531 0.000
202212 0.003 139.113 0.004
202303 0.002 145.950 0.002
202306 0.009 147.009 0.010
202309 0.020 146.113 0.022
202312 0.040 147.741 0.044
202403 0.034 149.044 0.037
202406 0.033 150.997 0.036
202409 0.012 153.439 0.013
202412 0.010 154.660 0.011
202503 0.004 157.021 0.004
202506 0.001 157.509 0.001
202509 0.000 158.000 0.000
202512 0.003 158.320 0.003
202603 0.000 163.070 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of zł0.00 mean?
MedTech Solutions (WAR:MDT) has a Cyclically Adjusted Revenue per Share of zł0.00 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MedTech Solutions and its competitors.
Is MedTech Solutions' Cyclically Adjusted Revenue per Share too high?
MedTech Solutions' current Cyclically Adjusted Revenue per Share is zł0.00. Overall, MedTech Solutions has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedTech Solutions' Cyclically Adjusted Revenue per Share compare to AMZN and BABA?
MedTech Solutions' Cyclically Adjusted Revenue per Share of zł0.00 can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Retail - Cyclical company?
A good Cyclically Adjusted Revenue per Share depends on the Retail - Cyclical industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MedTech Solutions and its competitors. MedTech Solutions's current Cyclically Adjusted Revenue per Share is zł0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Solutions stock overvalued right now?
Based on GuruFocus' analysis, MedTech Solutions (WAR:MDT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.04, compared to a current price of zł0.30 — trading 660% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is zł0.00. MedTech Solutions' overall GF Score™ is 39/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For MedTech Solutions (WAR:MDT), the current Cyclically Adjusted Revenue per Share is zł0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedTech Solutions (WAR:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued. The current stock price of zł0.30 is trading 660% above its estimated GF Value™ of zł0.04. GuruFocus considers MedTech Solutions to be Significantly Overvalued.

Key valuation signals for WAR:MDT:

  • Cyclically Adjusted Revenue per Share: zł0.00
  • GF Value™: zł0.04 vs. price of zł0.30 (660% above fair value)
  • GF Score™: 39/100 with 10 warning signs

No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedTech Solutions Business Description

Address Dluga 29, Warsaw, POL, 00-238
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
39GF Score

Get the complete analysis for WAR:MDT

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.30
Price
zł0.04
GF Value